Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.
about
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimensAcute Kidney Injury, Risk Factors, and Prognosis in Hospitalized HIV-Infected Adults in South Africa, Compared by Tenofovir Exposure.Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments.Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study.Assessment of renal function in routine care of people living with HIV on ART in a resource-limited setting in urban Zambia.Renal manifestations of HIV during the antiretroviral era in South Africa: a systematic scoping review.Renal outcomes in patients initiated on tenofovir disoproxil fumarate-based antiretroviral therapy at a community health centre in Malawi.Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review.Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial.Prevalence and correlates of chronic kidney disease (CKD) among ART-naive HIV patients in the Niger-Delta region of Nigeria.Approach to acute kidney injury in HIV-infected patients in South Africa.Prevalence and factors associated with renal dysfunction in patients on tenofovir disoproxil fumarate-based antiretroviral regimens for HIV infection in Southern India.Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis.Risk factors and co-morbidities associated with changes in renal function among antiretroviral treatment-naïve adults in South Africa: A chart review.
P2860
Q34536677-6F7DFCA8-3A19-4C3F-A6A2-8280D98946CEQ37263602-7164DC42-E84F-4EFF-A9C5-E3D10B9C01FAQ37588780-582C00CC-4135-4843-BECD-156645933362Q38821304-B6D97630-5BFB-478A-8D50-40FC0804E419Q40244089-A85956AF-0AB0-49BE-8769-3710085EBAE7Q41997086-8EA8F28B-A3BB-45C5-A04C-9C3B5CA5E787Q42377428-1EB5A144-6602-4D7F-B94B-1AEE281CA9B6Q47553173-40802943-354D-452E-BDAE-6DBEE117FD37Q47736998-87693C73-9D8B-42DC-9B08-22F88BD4228BQ50348041-D0AAB844-FDB2-4765-A601-285E0EDA865FQ52381407-F5025D00-4507-46A3-ABF9-711928DE05C6Q52641455-FB59FD61-69A5-41F3-9918-67591CDD6BE2Q52641469-4CBBB213-8CC9-4729-B618-0462F7BAA779Q53692625-12922555-B9AC-4FC5-91E9-3E33E42545C9Q55083905-2907A1D9-F8FD-41CC-B4A5-75E70660D75D
P2860
Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Renal impairment in HIV-infect ...... hcare Setting in South Africa.
@en
type
label
Renal impairment in HIV-infect ...... hcare Setting in South Africa.
@en
prefLabel
Renal impairment in HIV-infect ...... hcare Setting in South Africa.
@en
P2860
P50
P356
P1476
Renal impairment in HIV-infect ...... hcare Setting in South Africa.
@en
P2093
Francesca Little
Monika Kamkuemah
P2860
P304
P356
10.1111/TMI.12446
P577
2014-12-12T00:00:00Z